News & Events
Breaking news! CDE Released the List of 3rd Batch of Overseas New Drugs Urgently Needed in Clinical Settings
Abstract: most drugs are used for rare diseases. To implement the policies set forth in the State Council executive meetings and speed up the entry
What is the relationship between the National Health Commission of the People’s Republic of China, the National Healthcare Security Administration and the National Medical Products Administration?
Let’s talk about the difference between the National Health Commission of the People’s Republic of China, the National Healthcare Security Administration and the National Medical
Antidiabetic Drugs are About to Enter the Price Storm
The fourth batch of centralized procurement of drugs is expected to be officially launched around February 2021. While covering diabetes, hypertension, respiratory disease, psychotherapy, cancer,
NHSA Responds that Eligible Orphan Drugs are Basically Covered by Medical Insurance
On Dec 10, 2020, National Healthcare Security Administration (NHSA) replied that among more than 50 orphan drugs currently on the market with indications, more than
NMPA Consults on the Requirements and Templates of the Annual Report for MAH
On Dec 8, 2020, National Medical Products Administration (NMPA) issued the draft Provisions on the Administration of the Drug Annual Report and the draft Templates
GVP Is Coming! NMPA Consults on the Draft GVP (Good Pharmacovigilance Practices).
On Dec 1, 2020, National Medical Products Administration (NMPA) issued the draft Good Pharmacovigilance Practices (GVP) for public consultation, openly circulating for comments from the